Arcturus Therapeutics Holdings Inc. (ARCT) has a consensus analyst rating of Buy, based on 21 analysts covering the stock. Of those, 12 recommend buying, 5 recommend holding, and 4 recommend selling.
The analyst consensus price target for ARCT is $22.50, representing a +159.2% upside from the current price of $8.68. Price targets range from a low of $20.00 to a high of $25.00.
